All Stories

  1. AILMENT: A novel ML framework for prediction and analysis of microbiota associations in colorectal cancer
  2. Transition of oral microbiome profile in HIV-infected Indonesian patients: the role of antiretroviral therapy
  3. The Urinary Microbiome in Women Using Single‐Use Versus Reusable Catheters for Intermittent Catheterization: An Exploratory Substudy of the COMPaRE Trial
  4. Antimicrobial Peptides SET-M33L and SET-M33L-PEG Are Promising Agents Against Strong Biofilm-Forming P. aeruginosa, Including Multidrug-Resistant Isolates
  5. Antimicrobial resistance in Campylobacter spp. focussing on C. jejuni and C. coli – A narrative review
  6. BenchAMRking: a Galaxy-based platform for illustrating the major issues associated with current antimicrobial resistance (AMR) gene prediction workflows
  7. A Comprehensive Review of Recent Research into the Effects of Antimicrobial Peptides on Biofilms—January 2020 to September 2023
  8. First Report of Colistin-Resistant Escherichia coli Carrying mcr-1 IncI2(delta) and IncX4 Plasmids from Camels (Camelus dromedarius) in the Gulf Region
  9. Expert guidance on target product profile development for AMR diagnostic tests
  10. In vitro activity of novel apramycin-dextran nanoparticles and free apramycin against selected Dutch and Pakistani Klebsiella pneumonia isolates
  11. Extended Spectrum- and Carbapenemase-Based β-Lactam Resistance in the Arabian Peninsula—A Descriptive Review of Recent Years
  12. Datasets for benchmarking antimicrobial resistance genes in bacterial metagenomic and whole genome sequencing
  13. Perspectives on the Ethics of Antibiotic Overuse and on the Implementation of (New) Antibiotics
  14. The diagnostic value of nasal microbiota and clinical parameters in a multi-parametric prediction model to differentiate bacterial versus viral infections in lower respiratory tract infections
  15. Liquid Chromatography-Tandem Mass Spectrometry Analysis Demonstrates a Decrease in Porins and Increase in CMY-2 β-Lactamases in Escherichia coli Exposed to Increasing Concentrations of Meropenem
  16. Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
  17. OralDisk: A Chair-Side Compatible Molecular Platform Using Whole Saliva for Monitoring Oral Health at the Dental Practice
  18. Genetic Analysis of mcr-1-Carrying Plasmids From Gram-Negative Bacteria in a Dutch Tertiary Care Hospital: Evidence for Intrapatient and Interspecies Transmission Events
  19. The Role of the Respiratory Microbiome and Viral Presence in Lower Respiratory Tract Infection Severity in the First Five Years of Life
  20. CTX-M-15 Positive Escherichia coli and Klebsiella pneumoniae Outbreak in the Neonatal Intensive Care Unit of a Maternity Hospital in Ha’il, Saudi Arabia
  21. WeFaceNano: a user-friendly pipeline for complete ONT sequence assembly and detection of antibiotic resistance in multi-plasmid bacterial isolates
  22. The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective
  23. Salivary Biomarkers for Dental Caries Detection and Personalized Monitoring
  24. The Internet of Things for Combatting Antimicrobial Resistance
  25. NanoGalaxy: Nanopore long-read sequencing data analysis in Galaxy
  26. Rapid identification of Nocardia cyriacigeorgica from a brain abscess patient using MALDI-TOF-MS
  27. Comparison of Illumina versus Nanopore 16S rRNA Gene Sequencing of the Human Nasal Microbiota
  28. Biological Consequences of Psychological Distress in Caregivers of Children with Autism Spectrum Disorder and its Potential Relevance to Other Chronic Diseases Including Cancer
  29. Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats
  30. Lessons learnt from the introduction of nanopore sequencing?
  31. Comment on: “A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance”
  32. Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia–Septicemia Model in Rats
  33. Diversity, compositional and functional differences between gut microbiota of children and adults
  34. Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles
  35. Differences in Systemic IgA Reactivity and Circulating Th Subsets in Healthy Volunteers With Specific Microbiota Enterotypes
  36. Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory
  37. The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex ‘mix-and-match’ implementation package
  38. Antibiotic misuse in respiratory tract infections in children and adults—a prospective, multicentre study (TAILORED Treatment)
  39. Whole genome sequence analysis of NDM-1, CMY-4, and SHV-12 coproducing Salmonella enterica serovar Typhimurium isolated from a case of fatal burn wound infection
  40. Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections
  41. Developmental roadmap for antimicrobial susceptibility testing systems
  42. Monitoring of microbial dynamics in a drinking water distribution system using the culture-free, user-friendly, MYcrobiota platform
  43. Detection of Bacterial DNA in Septic Arthritis Samples Using the MYcrobiota Platform
  44. Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance
  45. Challenges in identifying antibiotic resistance targets for point-of-care diagnostics in general practice
  46. Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the “TAILORED-Treatment” study
  47. Anthrax protective antigen is a calcium-dependent serine protease
  48. Development and evaluation of a culture-free microbiota profiling platform (MYcrobiota) for clinical diagnostics
  49. Galaxy mothur Toolset (GmT): a user-friendly application for 16S rRNA gene sequencing analysis using mothur
  50. Characterization of the nasopharyngeal and middle ear microbiota in gastroesophageal reflux-prone versus gastroesophageal reflux non-prone children
  51. Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumon iae and P. aeruginosa
  52. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness
  53. Rise of Clostridium difficile infections
  54. Why is scientific research on ‘data-poor’ microorganisms being ignored?
  55. Novel micelle PCR-based method for accurate, sensitive and quantitative microbiota profiling
  56. Pre-implementation guidelines for infectious disease point-of-care testing in medical institutions
  57. Evaluation of the characteristics of leucyl-tRNA synthetase (LeuRS) inhibitor AN3365 in combination with different antibiotic classes
  58. ‘Out-of-the-box’ thinking to help stop the spread of antibiotic resistance
  59. Detection of Healthcare-Related Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Transmission Events Using Combined Genetic and Phenotypic Epidemiology
  60. Comment - Problems with interpretation of microbiota sequencing results
  61. Current problems associated with the microbiological point-of-care testing of respiratory tract infections in primary care
  62. Detection of amino acid substitutions in the GyrA protein of fluoroquinolone-resistant typhoidal Salmonella isolates using high-resolution mass spectrometry
  63. FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN
  64. A Polymorphism inleuSConfers Reduced Susceptibility to GSK2251052 in a Clinical Isolate of Staphylococcus aureus
  65. Antimicrobial resistance trends in blood culture positive Salmonella Paratyphi A isolates from Pondicherry, India
  66. Chair/bedside diagnosis of oral and respiratory tract infections, and identification of antibiotic resistances for personalised monitoring and treatment
  67. Micelle PCR reduces chimera formation in 16S rRNA profiling of complex microbial DNA mixtures
  68. Moraxella catarrhalis: A mini review
  69. A multifaceted ‘omics’ approach for addressing the challenge of antimicrobial resistance
  70. Plasmid-Mediated AmpC: Prevalence in Community-Acquired Isolates in Amsterdam, the Netherlands, and Risk Factors for Carriage
  71. Moraxella catarrhalis
  72. Whole-genome mapping for high-resolution genotyping of Pseudomonas aeruginosa
  73. Detection and Occurrence of Plasmid-Mediated AmpC in Highly Resistant Gram-Negative Rods
  74. Bacterial proteases: targets for diagnostics and therapy
  75. Evaluation of a FRET-Peptide Substrate to Predict Virulence in Pseudomonas aeruginosa
  76. Evaluation of a D-amino-acid-containing fluorescence resonance energy transfer peptide library for profiling prokaryotic proteases
  77. Perceptions of point-of-care infectious disease testing among European medical personnel, point-of-care test kit manufacturers, and the general public
  78. Comprehensive Antigen Screening Identifies Moraxella catarrhalis Proteins That Induce Protection in a Mouse Pulmonary Clearance Model
  79. Differential Virulence Gene Expression of Group A Streptococcus Serotype M3 in Response to Co-Culture with Moraxella catarrhalis
  80. The Papain Inhibitor (SPI) of Streptomyces mobaraensis Inhibits Bacterial Cysteine Proteases and Is an Antagonist of Bacterial Growth
  81. Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion
  82. Genome Analysis of Moraxella catarrhalis Strain RH4, a Human Respiratory Tract Pathogen
  83. Inflammation in the Middle Ear of Children With Recurrent or Chronic Otitis Media Is Associated With Bacterial Load
  84. New type F lineage-related Tn1546 and a vanA/vanB type vancomycin resistant Enterococcus faecium isolated from patients in Dammam, Saudi Arabia during 2006–2007 – ERRATUM
  85. New type F lineage-related Tn1546 and a vanA/vanB type vancomycin-resistant Enterococcus faecium isolated from patients in Dammam, Saudi Arabia during 2006–2007
  86. Antimicrobial resistance trends in blood culture positive Salmonella Paratyphi A isolates from Pondicherry, India, 2005 - 2009
  87. Comparative Analysis of the Humoral Immune Response to Moraxella catarrhalis and Streptococcus pneumoniae Surface Antigens in Children Suffering from Recurrent Acute Otitis Media and Chronic Otitis Media with Effusion
  88. Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh
  89. The Role of New Technologies in Medical Microbiological Research and Diagnosis
  90. Campylobacterbacteremia: A rare and under-reported event?
  91. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005–2009
  92. Highly Specific Protease-Based Approach for Detection of Porphyromonas gingivalis in Diagnosis of Periodontitis
  93. Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants
  94. Mobile Genetic Elements inMoraxella catarrhalis
  95. Moraxella
  96. Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates
  97. Molecular characterization of antimicrobial resistance in non-typhoidal salmonellae associated with systemic manifestations from India
  98. Colonization of healthy children by Moraxella catarrhalis is characterized by genotype heterogeneity, virulence gene diversity and co-colonization with Haemophilus influenzae
  99. Determinants of Moraxella catarrhalis colonization in healthy Dutch children during the first 14 months of life
  100. High prevalence of ST-78 infection-associated vancomycin-resistant Enterococcus faecium from hospitals in Asunción, Paraguay
  101. Genome Analysis of Moraxella catarrhalis Strain RH4, a Human Respiratory Tract Pathogen
  102. Important methodological considerations with respect to differentiation of CTX-M-15 and CTX-M-28 extended-spectrum beta-lactamases
  103. Molecular Aspects of Moraxella catarrhalis Pathogenesis
  104. bro β-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults
  105. The evaluation of putative endogenous control housekeeping genes for real-time polymerase chain reaction expression studies in Moraxella catarrhalis
  106. Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum  -lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay
  107. Molecular Aspects of Moraxella catarrhalis Pathogenesis
  108. The Application of Randomly Amplified DNA Analysis in the Molecular Epidemiology of Microorganisms
  109. Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001-2002
  110. Analysis of VanA vancomycin-resistant Enterococcus faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 and two new Tn1546 lineage types
  111. Principles and Technical Aspects of PCR Amplification
  112. High-throughput amplification fragment length polymorphism (htAFLP) analysis identifies genetic lineage markers but not complement phenotype-specific markers in Moraxella catarrhalis
  113. Unveiling electrotransformation ofMoraxella catarrhalisas a process of natural transformation
  114. Identification and Characterization of a Novel Outer Membrane Protein (OMP J) of Moraxella catarrhalis That Exists in Two Major Forms
  115. Moraxella catarrhalisis only a weak activator of the mannose-binding lectin (MBL) pathway of complement activation
  116. A novel plasmid (pEMCJH03) isolated from moraxella catarrhalis possibly useful as a cloning and expression vector within this species
  117. Pneumococcal vaccination does not affect the genetic diversity of Moraxella catarrhalis isolates in children
  118. Changes in genetic types and population dynamics of Moraxella catarrhalis in hospitalized children are not associated with an exacerbation of existing disease
  119. Total genome polymorphism and low frequency of intra-genomic variation in the uspA1 and uspA2 genes of Moraxella catarrhalis in otitis prone and non-prone children up to 2 years of age
  120. A Nucleic Acid Sequence–Based Amplification Method To Detect Salmonella enterica Serotype Enteritidis Strain PT4 in Liquid Whole Egg
  121. Diagnosis of Influenza in the Community
  122. Corrigendum
  123. An RNA transcription-based amplification technique (NASBA) for the detection of viable Salmonella enterica
  124. A ONE ‐ TUBE NUCLEIC ACID EXTRACTION AND AMPLIFICATION (ERTPCR) METHOD FOR DETECTING RNA VIRUSES
  125. PCR sequencing of the spike genes of geographically and chronologically distinct human coronaviruses 229E
  126. The Genus Moraxella